These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17689656)

  • 21. Combined continuous hormone replacement therapy: a critical review.
    Gambrell RD
    Obstet Gynecol; 1995 Nov; 86(5):869-70. PubMed ID: 7566870
    [No Abstract]   [Full Text] [Related]  

  • 22. Endometrial cancer--surprising reports.
    Speroff L
    Maturitas; 2005 Aug; 51(4):329-33. PubMed ID: 16039404
    [No Abstract]   [Full Text] [Related]  

  • 23. What influence does hormone replacement therapy have on endometrial cancer risk?
    Barakat RR
    Nat Clin Pract Oncol; 2005 Nov; 2(11):546-7. PubMed ID: 16270092
    [No Abstract]   [Full Text] [Related]  

  • 24. [The role of sex steroids for genesis of breast and endometrial cancer].
    Distler W
    Gynakologe; 1993 Apr; 26(2):94-9. PubMed ID: 8508990
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term dietary cadmium intake and postmenopausal endometrial cancer incidence: a population-based prospective cohort study.
    Akesson A; Julin B; Wolk A
    Cancer Res; 2008 Aug; 68(15):6435-41. PubMed ID: 18676869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
    Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
    Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
    [No Abstract]   [Full Text] [Related]  

  • 27. [Activated protein C resistance of an acquired nature: the potential role of hormonal treatment and of elevated factor VIII plasma levels].
    Iturbe Hernández T; Varo MJ; Olave MT; Fuertes MA; Cornudella R
    Rev Clin Esp; 1999 Sep; 199(9):618. PubMed ID: 10568160
    [No Abstract]   [Full Text] [Related]  

  • 28. Cigarette smoking and the risk of endometrial cancer: a meta-analysis.
    Zhou B; Yang L; Sun Q; Cong R; Gu H; Tang N; Zhu H; Wang B
    Am J Med; 2008 Jun; 121(6):501-508.e3. PubMed ID: 18501231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
    Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
    Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ["Fatal therapy": hormones and cancer--a medical enigma. No protection against pseudo-scientific misuse].
    Schneider HP
    Zentralbl Gynakol; 2000; 122(10):503-6. PubMed ID: 11072683
    [No Abstract]   [Full Text] [Related]  

  • 33. [Whether long-term use of oral contraceptives and hormone replacement therapy affects the pathology of mammary gland?].
    Stoĭkov S; Emin A; Baĭchev G
    Akush Ginekol (Sofiia); 2006; 45(4):33-7. PubMed ID: 16889198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hormone replacement therapy and cancer risk].
    Matsushita H; Wakatsuki A
    Nihon Rinsho; 2012 Jun; 70 Suppl 4():805-9. PubMed ID: 23156354
    [No Abstract]   [Full Text] [Related]  

  • 35. Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.
    Rexrode KM; Manson JE
    Circulation; 2007 Feb; 115(7):820-2. PubMed ID: 17309929
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hormone replacement therapy in postmenopausal women and breast cancer risk: impact of estrogens deprivation and timing hypothesis].
    Brettes JP; Mathelin C
    Gynecol Obstet Fertil; 2007 Nov; 35(11):1092-4. PubMed ID: 17996474
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic influence of hormone-replacement therapy on venous thromboembolism.
    Sumino H; Ichikawa S; Kumakura H; Takayama Y; Kurabayashi M
    Lancet; 2003 Oct; 362(9391):1242. PubMed ID: 14568759
    [No Abstract]   [Full Text] [Related]  

  • 38. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.
    Bouaziz E; Canonico M; Verstuyft C; Carcaillon L; Martin F; Scarabin PY; Guiochon-Mantel A;
    Maturitas; 2009 Oct; 64(2):136-8. PubMed ID: 19782484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Breast cancer and hormonal therapy.
    Conner P; Lundström E; von Schoultz B
    Clin Obstet Gynecol; 2008 Sep; 51(3):592-606. PubMed ID: 18677153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
    McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.